ProQR Therapeutics N.V. PRQR
PRQR
ProQR Therapeutics N.V. IMMP
Immutep Limited EDIT
Editas Medicine, Inc. CAPR
Capricor Therapeutics, Inc. ACHV
Achieve Life Sciences, Inc. ALLO
Allogene Therapeutics, Inc. ARCT
Arcturus Therapeutics Holdings Inc. MREO
Mereo BioPharma Group plc VNDA
Vanda Pharmaceuticals Inc. TRDA
Entrada Therapeutics, Inc.
ProQR Therapeutics N.V. IMMP
Immutep Limited EDIT
Editas Medicine, Inc. CAPR
Capricor Therapeutics, Inc. ACHV
Achieve Life Sciences, Inc. ALLO
Allogene Therapeutics, Inc. ARCT
Arcturus Therapeutics Holdings Inc. MREO
Mereo BioPharma Group plc VNDA
Vanda Pharmaceuticals Inc. TRDA
Entrada Therapeutics, Inc.
Performance
| Periode | PRQR | IMMP | EDIT | CAPR | ACHV | ALLO | ARCT | MREO | VNDA | TRDA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 30.85 % | 40.80 % | 24.11 % | 125.38 % | 38.46 % | 8.96 % | -41.44 % | -20.83 % | 47.45 % | 45.59 % |
| YTD | -10.22 % | 10.86 % | 86.64 % | 77.47 % | 21.95 % | -33.64 % | -57.53 % | -36.11 % | 37.97 % | -36.71 % |
| 1Y | -0.40 % | 17.79 % | 65.20 % | 91.28 % | 8.96 % | -29.13 % | -55.36 % | -36.67 % | 43.63 % | -38.65 % |
| 3Y | 48.19 % | 30.32 % | -75.57 % | 582.52 % | 80.00 % | -79.38 % | -60.25 % | 186.18 % | -4.73 % | -45.30 % |
| 5Y | -41.71 % | -28.99 % | -96.23 % | 529.15 % | -43.04 % | -94.83 % | -93.38 % | 0.23 % | -49.92 % | -53.86 % |
| 10Y | -64.71 % | -81.01 % | -86.57 % | -26.45 % | -99.82 % | -94.16 % | -82.33 % | -66.39 % | -23.91 % | -53.86 % |
| Depuis le début | -83.30 % | -98.17 % | -86.57 % | -94.10 % | -100.00 % | -94.16 % | -86.28 % | -66.39 % | -31.30 % | -53.86 % |